Lobbying Activity Report

1197-9883

Organization: Cystic Fibrosis Canada
Associated registration: 1476-1197-9
Lobbying Activity date: 2021-05-31
Arranged a meeting: No
Posted date: 2021-06-15

In-house lobbyists who participated in the lobbying activity: Kelly Grover
Senior Public Office Holders who were lobbied in this activity: Dan Ashton, MLA, Penticton
Health

Bruce Banman, MLA, Abbotsford South
Health

Mike Bernier, MLA, Peace River South
Health

Shirley Bond, MLA, Prince George-Valemount
Health

Stephanie Cadieux, MLA, Surrey South
Health

Doug Clovechok, MLA, Columbia River-Revelstoke
Health

Dan Davies, MLA, Peace River North
Health

Lorne Doerkson, MLA, Cariboo-Chilcotin
Health

Trevor Halford, MLA, Surrey-White Rock
Health

Karin Kirkpatrick, MLA, Vancouver-Capilano
Health

Greg Kyllo, MLA, Shuswap
Health

Michalel Lee, MLA, Vancouver-Langara
Health

Norm Letnick, MLA, Kelowna-Lake Country
Health

Renee Merrifield, MLA, Kelowna-Mission
Health

Peter Milobar, MLA, Kamloops-North Thompson
Health

Mike Morris, MLA, Prince George-MacKenzie
Health

Coralee Oakes, MLA, Cariboo North
Health

Ian Paton, MLA, Delta South
Health

Ellis Ross, MLA, Skeena
Health

John Rustad, MLA, Nechako Lakes
Health

Tom Shypitka, MLA, Kootenay East
Health

Ben Stewart, MLA, Kelowna West
Health

Todd Stone, MLA, Kamloops-South Thompson
Health

Jordan Study, MLA, West Vancouver-Sea to Sky
Health

Jackie Tegart, MLA, Fraser-Nicola
Health

Teresa Wat, MLA, Richmond North Centre
Health

Andrew Wilkinson, MLA, Vancouver-Quilchena
Health

Michael de Jong, MLA, Abbotsford-West
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
We are calling on the BC government to fund Trikafta immediately upon Health Canada approval with the broadest prescribing criteria possible and to fund Kalydeco and Orkambi immediately upon Health Canada approval of Trikafta with the broadest prescribing criteria possible.
To improve the quality of CF care through the implementation of an integrated, provincial program for cystic fibrosis, including access to mental health services.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Kelly Grover
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: